Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Teismann

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Neurogenetics|September 18, 2009
Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in miceSilke Nuber, Thomas Franck, Hartwig Wolburg, et al.
Neurobiology of Disease|July 20, 2011
Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stagesSilke Nuber, Elisabeth Petrasch-Parwez, Oscar Arias-Carrión, et al.
Molecular and Cellular Biology|October 29, 2004
Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in miceL Miguel Martins, Alastair Morrison, Kristina Klupsch, et al.
Journal of Neurochemistry|April 1, 2006
Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's diseaseKatrin Meuer, Claudia Pitzer, Peter Teismann, et al.
Brain : a Journal of Neurology|February 16, 2013
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic ratsSilke Nuber, Florian Harmuth, Zacharias Kohl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2008
Neurodegeneration and motor dysfunction in a conditional model of Parkinson's diseaseSilke Nuber, Elisabeth Petrasch-Parwez, Beate Winner, et al.
Glia|March 4, 2015
Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanismChristiane Menzfeld, Michael John, Denise van Rossum, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Neurogenetics|September 18, 2009
Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in miceSilke Nuber, Thomas Franck, Hartwig Wolburg, et al.
Neurobiology of Disease|July 20, 2011
Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stagesSilke Nuber, Elisabeth Petrasch-Parwez, Oscar Arias-Carrión, et al.
Molecular and Cellular Biology|October 29, 2004
Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in miceL Miguel Martins, Alastair Morrison, Kristina Klupsch, et al.
Journal of Neurochemistry|April 1, 2006
Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's diseaseKatrin Meuer, Claudia Pitzer, Peter Teismann, et al.
Brain : a Journal of Neurology|February 16, 2013
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic ratsSilke Nuber, Florian Harmuth, Zacharias Kohl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2008
Neurodegeneration and motor dysfunction in a conditional model of Parkinson's diseaseSilke Nuber, Elisabeth Petrasch-Parwez, Beate Winner, et al.
Glia|March 4, 2015
Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanismChristiane Menzfeld, Michael John, Denise van Rossum, et al.
Pageof 4